Plain-English translation of NCT05509777 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Crohn's Disease research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called in children and young people with Crohn's disease that is still causing significant symptoms even after trying other treatments. is given as an injection under the skin or into a vein, with the dose adjusted based on the child's weight. The trial hopes to show whether this medication can help reduce inflammation and improve symptoms in children who haven't had good results with existing treatments.
Crohn's disease in children can be serious and difficult to manage, and some children don't respond well to current medications. Researchers are testing this medication to see if it offers a new option for young patients whose disease isn't controlled by other available treatments.
You likely qualify if…
You likely don't qualify if…
If you are selected, you will receive either as an injection under your skin or as an infusion into your vein. The dose and method of injection will be determined by your child's weight. You will need to attend study visits for medical exams, blood tests, and endoscopy procedures to check how well the medication is working and to monitor for any side effects.
AI-generated summary from trial data · Aug 26, 2026 · Not medical advice
United States